TARS vs GILD: Which Stock is Better?
Side-by-side comparison of Tarsus Pharmaceuticals Inc and Gilead Sciences Inc in 2026
TARS
Tarsus Pharmaceuticals Inc
$63.48
GILD
Gilead Sciences Inc
$130.40
Key Metrics Comparison
| Metric | TARS | GILD | Winner |
|---|---|---|---|
| Market Cap | $2.75B | $161.85B | GILD |
| P/E Ratio | N/A | 19.23 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 1.3% | 0.0% | TARS |
| Gross Margin | 79.0% | 78.8% | TARS |
Analyze TARS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARS or GILD a better investment?
Comparing TARS and GILD: Tarsus Pharmaceuticals Inc has a market cap of $2.75B while Gilead Sciences Inc has $161.85B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARS and GILD?
TARS (Tarsus Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARS or GILD?
TARS has higher revenue growth at 1.3% vs 0.0% for GILD.
Which company is more profitable: TARS or GILD?
Tarsus Pharmaceuticals Inc (TARS) has higher gross margins at 79.0% compared to 78.8% for GILD.
Which is the larger company: TARS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $161.85B compared to $2.75B for TARS.
Should I buy TARS or GILD in 2026?
Both TARS and GILD have investment merit. TARS trades at $63.48 while GILD trades at $130.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARS and GILD stock?
Key differences: Market Cap ($2.75B vs $161.85B), P/E Ratio (N/A vs 19.2x), Revenue Growth (1.3% vs 0.0%), Gross Margin (79.0% vs 78.8%).